|
|
|
|
| LEADER |
04535nam a2200529 4500 |
| 001 |
ocn893740492 |
| 003 |
OCoLC |
| 005 |
20180501122022.0 |
| 006 |
m o d |
| 007 |
cr cnu---unuuu |
| 008 |
141025s2014 caua ob 001 0 eng d |
| 040 |
|
|
|a EBLCP
|b eng
|e pn
|c EBLCP
|d N$T
|d OCLCQ
|d N$T
|d UIU
|d YDXCP
|d IDEBK
|d OCLCQ
|d UAB
|d OCLCQ
|d BNG
|d OCLCO
|e rda
|d MEU
|d GrThAP
|
| 019 |
|
|
|a 899277705
|
| 020 |
|
|
|a 9780128003381
|q (electronic bk.)
|
| 020 |
|
|
|a 0128003383
|q (electronic bk.)
|
| 020 |
|
|
|a 9780128002827
|
| 020 |
|
|
|a 0128002824
|
| 035 |
|
|
|a (OCoLC)893740492
|z (OCoLC)899277705
|
| 050 |
|
4 |
|a QP375.5
|
| 050 |
|
4 |
|a RM301.25
|b .P42883 2014eb
|
| 072 |
|
7 |
|a MED
|x 075000
|2 bisacsh
|
| 072 |
|
7 |
|a SCI
|x 036000
|2 bisacsh
|
| 082 |
0 |
4 |
|a 612.824
|2 23
|
| 049 |
|
|
|a TEFA
|
| 245 |
0 |
0 |
|a Pharmacology of the Blood Brain Barrier :
|b Targeting CNS Disorders /
|c edited by Thomas P. Davis.
|
| 246 |
3 |
|
|a Pharmacology of the Blood-Brain Barrier
|
| 250 |
|
|
|a First edition.
|
| 264 |
|
1 |
|a San Diego, CA :
|b Academic Press,
|c 2014.
|
| 300 |
|
|
|a 1 online resource (xvi, 495 pages :
|b illustrations).
|
| 336 |
|
|
|a text
|b txt
|2 rdacontent
|
| 337 |
|
|
|a computer
|b c
|2 rdamedia
|
| 338 |
|
|
|a online resource
|b cr
|2 rdacarrier
|
| 490 |
1 |
|
|a Advances in pharmacology ;
|v volume 71
|
| 546 |
|
|
|a Text in English.
|
| 588 |
0 |
|
|a Print version record.
|
| 504 |
|
|
|a Includes bibliographical references and index.
|
| 520 |
|
|
|a This new volume of Advances in Pharmacology presents pharmacology of the blood brain barrier, focusing on targeting CNS disorders. With a variety of chapters and the best authors in the field, the volume is an essential resource for pharmacologists, immunologists and biochemists alike.
|
| 505 |
0 |
0 |
|t ABC transporter regulation by signaling at the blood-brain barrier : relevance to pharmacology /
|r David S. Miller --
|t P-glycoprotein trafficking as a therapeutic target to optimize CNS drug delivery /
|r Thomas P. Davis, Lucy Sanchez-Covarubias, Margaret E. Tome --
|t Functional expression of drug transporters in glial cells : potential role on drug delivery to the CNS /
|r Tamima Ashraf, Amy Kao, Reina Bendayan --
|t Blood-brain barrier Na transporters in ischemic stroke /
|r Martha E. O'Donnell --
|t Transcytosis of macromolecules at the blood-brain barrier /
|r Jane E. Preston, N. Joan Abbott, David J. Begley --
|t Drug delivery to the ischemic brain /
|r Brandon J. Thompson, Patrick T. Ronaldson --
|t Delivery of chemotherapeutics across the blood-brain barrier : challenges and advances /
|r Nancy D. Doolittle, Leslie L. Muldoon, Aliana Y. Culp, Edward A. Neuwelt --
|t Delivery of antihuman African trypanosomiasis drugs across the blood-brain and blood-CSF barriers /
|r Gayathri N. Sekhar, Christopher P. Watson, Mehmet Fidanboylu, Lisa Sanderson, Sarah A. Thomas --
|t Delivery of therapeutic peptides and proteins to the CNS /
|r Therese S. Salameh, William A. Banks --
|t Engineering and pharmacology of blood-brain barrier-permeable bispecific antibodies /
|r Danica Stanimirovic, Kristin Kemmerich, Arsalan S. Haqqani, Graham K. Farrington --
|t Pharmacological significance of prostaglandin E2 and D2 transport at the brain barriers /
|r Masanori Tachikawa, Ken-ichi Hosoya, Tetsuya Terasaki --
|t Steroids and the blood-brain barrier : therapeutic implications /
|r Ken A. Witt, Karin E. Sandoval --
|t Combination approaches to attenuate hemorrhagic transformation after tPA thrombolytic therapy in patients with poststroke hyperglycemia/diabetes /
|r Xiang Fan, Yinghua Jiang, Zhanyang Yu, Jing Yuan, Xiaochuan Sun, Shuanglin Xiang, Eng H. Lo, Xiaoying Wang --
|t Aging, the metabolic syndrome, and ischemic stroke : redefining the approach for studying the blood-brain barrier in a complex neurological disease /
|r Brandon P. Lucke-Wold, Aric F. Logsdon, Ryan C. Turner, Charles L. Rosen, Jason D. Huber --
|t Drug abuse and the neurovascular unit /
|r Richard D. Egleton, Thomas Abbruscato.
|
| 650 |
|
0 |
|a Blood-brain barrier
|x Effect of drugs on.
|
| 650 |
|
0 |
|a Nervous system
|x Degeneration
|x Chemotherapy.
|
| 650 |
|
7 |
|a MEDICAL
|x Physiology.
|2 bisacsh
|
| 650 |
|
7 |
|a SCIENCE
|x Life Sciences
|x Human Anatomy & Physiology.
|2 bisacsh
|
| 655 |
|
4 |
|a Electronic books.
|
| 700 |
1 |
|
|a Davis, Thomas P.
|c (Pharmacologist),
|e editor.
|
| 776 |
0 |
8 |
|i Print version:
|t Pharmacology of the blood brain barrier
|d Burlington : San Diego, CA : Academic Press, 2014
|z 9780128002827
|w (OCoLC)899354977
|
| 830 |
|
0 |
|a Advances in pharmacology (San Diego, Calif.) ;
|v v. 71.
|
| 856 |
4 |
0 |
|u https://www.sciencedirect.com/science/bookseries/10543589/71
|z Full Text via HEAL-Link
|
